首页> 美国卫生研究院文献>Journal of the National Medical Association >Management and in-hospital outcome of patients with first episode of acute myocardial infarction: impact of diabetes mellitus.
【2h】

Management and in-hospital outcome of patients with first episode of acute myocardial infarction: impact of diabetes mellitus.

机译:急性心肌梗塞首发患者的管理和住院结局:糖尿病的影响。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The aim of this study is to compare clinical characteristics, management, complications, in-hospital outcome and mortality of diabetic and nondiabetic patients after the first episode of acute myocardial infarction (MI). This retrospective case-matched study included 60 diabetic and 55 non-diabetic patients. Medical information about patients was retrieved from the hospital recordings. Diabetic patients were older, were more hypertensive and had more coronary artery disease history than nondiabetic patients. The frequency of use of acute reperfusion therapy modalities was not statistically different between the two groups. Diabetes was a significant determinant against the use of beta blockers (OR=0.26; 95% CI 0.06-0.95) but in favor of angiotensin converting enzyme inhibitors (OR=3.3; 95% CI 1.17-9.36), whereas diabetes did not influence the use of other drugs. Diabetic patients had more complications than nondiabetic patients (40.0% and 16.3%, respectively, p=0.005). In-hospital mortality rate for diabetic patients was comparable to nondiabetic patients (16.7% and 10.9%, respectively, p=0.373). Pharmaceutical treatment regimens, particularly beta blockers, are underutilized after acute MI in diabetic patients. More frequent use of these regimens will improve the high complication and mortality rates in diabetic patients as well as in nondiabetic patients.
机译:这项研究的目的是比较急性心肌梗塞(MI)首次发作后的糖尿病和非糖尿病患者的临床特征,治疗,并发症,院内结局和死亡率。这项回顾性病例匹配研究包括60例糖尿病患者和55例非糖尿病患者。从医院记录中检索了有关患者的医疗信息。与非糖尿病患者相比,糖尿病患者年龄更大,血压更高并且有更多的冠状动脉疾病史。两组之间使用急性再灌注疗法的频率无统计学差异。糖尿病是决定是否使用β受体阻滞剂的重要决定因素(OR = 0.26; 95%CI 0.06-0.95),但赞成使用血管紧张素转化酶抑制剂(OR = 3.3; 95%CI 1.17-9.36),而糖尿病并没有影响使用其他药物。糖尿病患者的并发症要多于非糖尿病患者(分别为40.0%和16.3%,p = 0.005)。糖尿病患者的院内死亡率与非糖尿病患者相当(分别为16.7%和10.9%,p = 0.373)。糖尿病患者急性心肌梗死后药物治疗方案,尤其是β受体阻滞剂未得到充分利用。这些方案的更频繁使用将改善糖尿病患者以及非糖尿病患者的高并发症和死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号